Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000052

Drug Information
NameBupropion    
SynonymsBupropion Hcl; 34841-36-6 (hydrochloride); BSPBio_000038; AC1L198Y; KBioGR_001168; KBio2_004711; CPD000472526; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; Bupropion (Old RN); BRD-A05186015-003-05-7; UNII-01ZG3TPX31; SMR000472526; Elont; .alpha.-(tert-Butylamino)-m-chloropropiophenone; MolPort-003-845-432; (+-)-Bupropion; KBio1_001994; SAM001246699; L000725; ( -)-2-(tert-Butylamino)-3'-chlorpropiophenon; Amfebutamone; MLS001424015; Amfebutamona; BPBio1_000042; alpha-(tert-butylamino)-m-chloropropiophenone; BSPBio_002247; DB01156; 34911-55-2; 2-(Tert-Butylamino)-3'-chloropropiophenone; 1-Propanone, 1-(3-chlorophenyl)-2-[(1, 1-dimethylethyl)amino]-; Propiophenone, 2-(tert-butylamino)-3'-chloro-; KBio2_007279; Prestwick0_000249; Spectrum_001663; KBioSS_002143; D07591; Lopac0_000166; AMFEBUTAMONE HCl; Bupropion hydrocloride; CHEBI:3219; AC-197; Bupropion (USAN); Bupropion (INN); Amfebutamonum [INN-Latin]; Spectrum2_001659; Bupropion SR; NCGC00015122-06; Jsp006301; LS-122817; KBio3_001467; 1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-; Spectrum4_000614; BRN 2101062; TL8002604; Spectrum3_000644; Amfebutamona [INN-Spanish]; NCI60_002714; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; Prestwick3_000249; 1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, (+-)-; AB00053756; HMS2051G10; Amfebutamon; Bupropion [INN:BAN]; Prestwick1_000249; Spectrum5_001406; C06860; Prestwick2_000249; SPBio_001817; bupropion; CHEMBL894; CID444; KBio2_002143; 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-; amfebutamonum; SPBio_002257; 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, ()-; DivK1c_007050; HMS2089G14; ( -)-2-(tert-Butylamino)-3'-chloropropiophenone; 34841-39-9; SpecPlus_000954; NCGC00089751-02; NSC315851; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one    
CompanyGlaxoSmithKline plc    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassCentral Nervous System Agents    
CAS NumberCAS 34841-39-9
FormularC13H18ClNO    
PubChem Compound IDCID 444.    
PubChem Substance IDSID 9078.    
ChEBI3219;    
SuperDrug ATC IDN07BA02;    
SuperDrug CAS ID034911552;    
TargetNorepinephrine reuptakeInhibitor[2]
Norepinephrine reuptakeMultitarget[2]
Serotonin reuptakeInhibitor[2]
Serotonin reuptakeMultitarget[2]
Ref 1Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. To Reference
Ref 2Clinically relevant drug interactions with new generation antidepressants and antipsychotics. Ther Umsch. 2009 Jun;66(6):485-92. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543